Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy.
about
Epicutaneous immunotherapy (EPIT) blocks the allergic esophago-gastro-enteropathy induced by sustained oral exposure to peanuts in sensitized miceIntact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy (EPIT) in miceAllergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific ImmunotherapyAntigen-specific tolerance in immunotherapy of Th2-associated allergic diseases.Allergen-specific immunotherapy: is it vaccination against toxins after all?Transcutaneous immunotherapy via laser-generated micropores efficiently alleviates allergic asthma in Phl p 5-sensitized mice.Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated micropores.Laser-facilitated epicutaneous immunotherapy to IgE-mediated allergy.Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials.Generation of hypoallergenic neoglycoconjugates for dendritic cell targeted vaccination: a novel tool for specific immunotherapyAllergen immunotherapy: a centenary celebrationEpicutaneous Immunotherapy Compared with Sublingual Immunotherapy in Mice Sensitized to Pollen (Phleum pratense)New routes for allergen immunotherapy.The Role of Skin Barrier in the Pathogenesis of Food AllergyHeat-labile Escherichia coli toxin enhances the induction of allergen-specific IgG antibodies in epicutaneous patch vaccination.Revisiting the tolerogenicity of epidermal Langerhans cells.Pediatric food allergy and mucosal tolerance.An update on immunotherapy for food allergy.Role of dendritic cells in atopic dermatitis: an update.Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy?One century of allergen-specific immunotherapy for respiratory allergy.One hundred years of allergen immunotherapy European Academy of Allergy and Clinical Immunology celebration: review of unanswered questions.Novel routes for allergen immunotherapy: safety, efficacy and mode of action.Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches.Specific immunotherapy in grass pollen allergy.New directions in immunotherapy.A comparison of immunotherapy delivery methods for allergen immunotherapy.New approaches to transcutaneous immunotherapy: targeting dendritic cells with novel allergen conjugates.Pharmacotherapy of allergic rhinitis: current options and future perspectives.Emerging drugs for allergic conjunctivitis.Investigational drugs for the treatment of allergic rhinitis.Arguing the misconceptions in allergen-specific immunotherapy.Modified allergens and their potential to treat allergic disease.Epicutaneous immunotherapy for food allergy as a novel pathway for oral tolerance induction.Allergen immunotherapy in allergic rhinitis: current use and future trends.The efficiency of peptide immunotherapy for respiratory allergy.Novel strategies for the treatment of grass pollen-induced allergic rhinitis.Allergen immunotherapy: routes, safety, efficacy, and mode of action.Investigational new drugs for allergic rhinitis.Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper.
P2860
Q21134766-C020FC00-DBCD-4AE5-AE1E-1E70797A35F0Q21195867-BE21A6FE-841B-4459-AA15-8B9CE41CDEC9Q26852113-9BB94484-2CE2-4983-9FD7-D849194902CEQ27687250-70B8DC53-3562-4F0B-90C7-A3582BDC0A9AQ30248317-B7C23800-FDC3-4B3C-ABD3-6B4C33B4D9EFQ34402672-2BE71303-6A19-4061-8616-71BC0AE3D4ACQ34527154-B869816D-7A5F-4CE3-8FBE-540ED51A92A4Q36033148-7CB8FB13-AB14-41D4-9D74-D511AE3C7435Q36302500-89204358-0B51-46EC-884C-1C4645EB0D4AQ36549691-313E80CC-B52B-4FA3-BE91-040DDE7F0E68Q36834569-EFCC164F-271C-4692-A2BA-43AC208E2571Q36858368-C18C702E-3D0F-4DC9-82A3-49F35E66F8C7Q36864957-E094AD06-DA1E-4DE3-BC39-D20C014ECAB9Q37055921-B286EBFE-DEC6-48CE-BF50-01CD2409E918Q37561165-AB4BC14D-7A4E-4D0D-B583-44DE28916DA0Q37704952-F42F7FE9-2E97-4DF7-A48C-2844C2B7282EQ37761046-33C88C71-8725-4644-815A-B5111F837B26Q37790586-79142380-1A14-46ED-8E33-3FFEB4269FB2Q37823416-8D44F48E-178A-45D4-B45C-7E2A633141EAQ37868794-890D9663-C9B9-44AD-B5C9-17883E72A50CQ37873483-E3E25F6F-44AB-429E-8421-DC6BCCBB001BQ37981739-8C1B6586-7F0A-4D9E-A628-792663B516A0Q37984572-0862D405-4107-43C7-85FC-37BB487B4FE7Q38013789-8B79C8B0-3359-42EE-AD26-A5BBF438DB13Q38055324-637489AC-3CDA-427D-9673-31CD4879DD7DQ38073718-4A3DE58E-F954-4375-9C62-8E6ED0BF9DC7Q38103286-08D7DAB6-A34F-4876-A96C-9B5D0BA0CE3BQ38156306-AE9D6314-B2CE-4967-8BCB-168DC6AE7EE5Q38161991-2BA333B3-E177-47FF-9A0C-ADB5E50CE100Q38198760-11D7E861-F9C1-4C3F-8652-97B553B8A295Q38202695-F0223674-2220-41A4-8BD4-4A118597E233Q38217592-C5C2ACFA-F159-4A5F-8C02-150DFD2818E6Q38255585-87B52CF7-E6EC-41A9-9C87-EAEC6F3A532CQ38638657-F65B0821-D336-418B-ABBA-716272562249Q38680655-21090CBD-5ACC-4889-AA12-76F662F6C500Q38744223-FE6DD242-71FD-477F-8F32-3552608CC251Q38857421-FCCD96F5-30E2-426B-A072-8355A0D80475Q38912244-8FBE6017-0699-4F48-A153-7D6D2BE52203Q39111947-1BDC26E2-BDB1-4E70-B25D-26F1CBF9E8ADQ39115606-0122B906-05BE-49E7-AFB8-1A4053D12364
P2860
Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Epicutaneous allergen administ ...... lergen-specific immunotherapy.
@en
Epicutaneous allergen administ ...... lergen-specific immunotherapy.
@nl
type
label
Epicutaneous allergen administ ...... lergen-specific immunotherapy.
@en
Epicutaneous allergen administ ...... lergen-specific immunotherapy.
@nl
prefLabel
Epicutaneous allergen administ ...... lergen-specific immunotherapy.
@en
Epicutaneous allergen administ ...... lergen-specific immunotherapy.
@nl
P2093
P1476
Epicutaneous allergen administ ...... lergen-specific immunotherapy.
@en
P2093
Gabriela Senti
Nadine Rüedi
Nicole Graf
Pål Johansen
Seraina von Moos
Susanne Haug
Theodor Sonderegger
Thomas M Kündig
P304
P356
10.1016/J.JACI.2009.07.019
P407
P577
2009-09-05T00:00:00Z